Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of peripheral artery disease (PAD)
3.2.1.2 Rising prevalence of hearing loss
3.2.1.3 Technological advancements
3.2.1.4 Increased awareness and diagnosis
3.2.1.5 Supportive government initiatives
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of devices and treatment
3.2.2.2 Lack of knowledge regarding hearing loss
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Future market trends
3.6 Regulatory landscape
3.7 Product pipeline analysis
3.8 Reimbursement scenario
3.9 Porter’s analysis
3.10 PESTEL analysis
3.11 Gap analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Treatment Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Devices
5.2.1 Hearing aids
5.2.1.1 Behind-the-ear (BTE)
5.2.1.2 Receiver in the ear/receiver in canal (RITE/RIC)
5.2.1.3 Completely-in-the-canal/invisible-in-canal (CIC/IIC)
5.2.1.4 In-the-ear (ITE)
5.2.1.5 In-the-canal (ITC)
5.2.2 Cochlear implants
5.2.2.1 Unilateral implants
5.2.2.2 Bilateral implants
5.2.3 Bone-anchored hearing aids (BAHA)
5.2.4 MEI
5.3 Drugs
5.3.1 Systemic steroids
5.3.2 Antiviral medication
5.3.3 Vasodilators
5.3.4 Other drugs
Chapter 6 Market Estimates and Forecast, By Condition, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Sensorineural hearing loss
6.3 Conductive hearing loss
6.4 Mixed hearing loss
Chapter 7 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Otology clinics
7.4 Ambulatory surgical centers
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Bayer
9.2 Cochlear Ltd
9.3 Demant A/S
9.4 Eargo, Inc
9.5 GlaxoSmithKline
9.6 GN Store Nord A/S
9.7 Pfizer
9.8 Sonova Holding AG
9.9 Starkey
9.10 WS Audiology
